Previous 10 | Next 10 |
2023-09-08 07:27:23 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-market stock movers are a hot topic worth checking out on Friday with a look at today’s winners and losers! Moving stocks this morning are financial agreements, an earnings repor...
2023-08-18 11:45:16 ET More on Impel NeuroPharma Impel Pharma Non-GAAP EPS of -$0.97 beats by $0.06, revenue of $5.01M misses by $0.24M Impel cut to Neutral at Wedbush on sales outlook for migraine therapy Impel stock rises as dosing begins in mid-stage trial of INP1...
2023-08-16 13:38:03 ET Gainers: EBET ( EBET ) +160% . Novo Integrated Sciences ( NVOS ) +71% . Tivic Health Systems ( TIVC ) +58% . WeTrade Group ( WETG ) +43%. DLocal Limited ( DLO ) +35% . JX Luxventure Limited ( JXJT )...
2023-08-16 10:08:58 ET Gainers: Novo Integrated Sciences ( NVOS ) +86% . Aeon Biopharma ( AEON ) +11% . Biophytis ( BPTS ) +10% . Syros Pharmaceuticals ( SYRS ) +9% . MediciNova ( MNOV ) +8% . Losers: Impel Pharmaceuticals...
2023-08-16 08:33:15 ET Sacks Parente Golf ( SPGC ) -38% . Impel Pharmaceuticals ( IMPL ) -36% . SRM Entertainment ( SRM ) -22% announces pricing of its initial public offering . Coherent Corp. ( COHR ) -22% . after Q4 earning release . ...
2023-08-15 18:04:50 ET More on Impel NeuroPharma Impel NeuroPharma Non-GAAP EPS of -$0.97 beats by $0.06, revenue of $5.01M misses by $0.24M Impel cut to Neutral at Wedbush on sales outlook for migraine therapy For further details see: Impel Pharma says Chapter 1...
2023-07-06 08:32:06 ET Allarity Therapeutics ALLR -53% after pricing public offering to $11M ASLAN Pharmaceuticals Limited ( ASLN ) -33% to host webcast on July 6, 2023, to discuss phase 2b topline data from TREK-AD trial evaluating Eblasakimab in atopic dermatitis. ...
2023-07-05 13:00:26 ET Gainers: Mullen Automotive ( MULN ) +47% . iMedia Brands ( IMBI ) +45% . LightPath Technologies ( LPTH ) +32% . Cibus ( CBUS ) +34% . Impel Pharmaceuticals ( IMPL ) +29% . BioXcel Therapeutics ( BTAI ...
2023-07-05 10:02:39 ET Gainers: Impel Pharmaceuticals ( IMPL ) +32% . Adicet Bio ( ACET ) +18% . C4 Therapeutics ( CCCC ) +17% . NLS Pharmaceutics ( NLSP ) +7% . Poseida Therapeutics ( PSTX ) +4% . Losers: Amneal Pharmaceu...
Real-World Assessment Suggests that Concomitant Preventive and Acute Medication Use Decreases in Patients Using Trudhesa Additional Poster Underscores the Need for Non-Oral Treatment Options Given the Prevalence of Pre-Existing Gastrointestinal Disorders Among Those Prescribed Trudhesa ...
News, Short Squeeze, Breakout and More Instantly...
Impel Pharmaceuticals Inc. Company Name:
IMPL Stock Symbol:
NASDAQ Market:
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Impel Pharmaceuticals Inc. (IMPL) is expected to report for Q3 2023
2023-10-05 09:39:40 ET DENVER, Colo., Oct 5, 2023 ( www.247marketnews.com )- Impel Pharmaceuticals Inc. (NASDAQ: IMPL) stated, this morning, that it is exploring strategic alternatives and plans to consider a wide range of options with a focus on maximizing shareholder value, including ...